EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Xiaosu Zhou iD, Xue Chen iD, Jiaqi Chen iD, Lijun Wen, Zhanglin Zhang, Ya-Zhen Qin iD, Panxiang Cao iD, Haizhou Xing iD, Yingchang Mi, Wei Wang, Guangsen Zhang, Ji Li iD und 34 weitere

Blood · 2024

DOI: 10.1182/blood.2024023883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2024. Verfasst von Xiaosu Zhou und 45 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Retinoic Acid Receptor alpha, Oncogene Proteins, Fusion, Retinoic Acid Receptor gamma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atypical acute promyelocytic leukemia (aAPL) presents a complex landscape of retinoic acid receptor (RAR) fusion genes beyond the well-known PML::RARA fusion. Among these, 31 individually rare RARA and RARG fusion genes have been documented, often reported in the canonical X::RAR bipartite fusion form. Intriguingly, some artificially mimicked bipartite X::RAR fusions respond well to all-trans retinoic acid (ATRA) in vitro, contrasting with the ATRA resistance observed in patients. To unravel the underlying mechanisms, we conducted a comprehensive molecular investigation into the fusion transcripts in 27 RARA fusion gene–positive aAPL (RARA-aAPL) and 21 RARG-aAPL cases. Our analysis revealed an unexpected novel form of X::RAR::X– or X::RAR::Y–type tripartite fusions in certain RARA-aAPL and all RARG-aAPL cases, with shared features and notable differences between these 2 disease subgroups. In RARA-aAPL cases, the occurrence of RARA 3′ splices was associated with their 5′ fusion partner genes, mapping across the coding region of helix 11_12 (H11_12) within the ligand-binding domain (LBD), resulting in LBD-H12 or H11_12 truncation. In RARG-aAPL cases, RARG 3′ splices were consistently localized to the terminus of exon 9, leading to LBD-H11_12 truncation. Significant differences were also observed between RARA and RARG 5′ splice patterns. Our analysis also revealed extensive involvement of transposable elements in constructing RARA and RARG 3′ fusions, suggesting transposition mechanisms for fusion gene ontogeny. Both protein structural analysis and experimental results highlighted the pivotal role of LBD-H11_12/H12 truncation in driving ATRA unresponsiveness and leukemogenesis in tripartite fusion–positive aAPL, through a protein allosteric dysfunction mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Promyelocytic, AcuteRetinoic Acid Receptor alphaOncogene Proteins, FusionRetinoic Acid Receptor gammaHumansReceptors, Retinoic AcidMaleTretinoinFemale

Substanzen

Retinoic Acid Receptor alphaOncogene Proteins, FusionRARA protein, humanRetinoic Acid Receptor gammaReceptors, Retinoic AcidTretinoin

Autor:innen und Institutionen

  • Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China.
  • Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation C…
  • Department of Blood Transfusion, First Affiliated Hospital of Nanchang University, Jiangxi Key Laboratory of transfusion, Institute of Transfusion, Jiangxi Academy of Clinical Medical Sciences, Jiangxi Medical College,…
  • Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Xiaosu Zhou, Xue Chen, Jiaqi Chen, Ya-Zhen Qin, Panxiang Cao, Haizhou Xing, Ji Li, Tong Wang, Xian Zhang, Zhihua Zhang, Linya Wang, Xia Xiao, Kai Sun, Ran Gao, Huyong Zheng, Yanli Zhao, Peihua Lu, Suning Chen, Hongxing Liu

Zitieren

APA

Zhou, X., Chen, X., Chen, J., Wen, L., Zhang, Z., Qin, Y. Z., Cao, P., Xing, H., Mi, Y., Wang, W., Zhang, G., Li, J., Wu, H., Zhang, Z., Zhang, J., Su, Z., Wang, F., Zhang, Y., Ma, X., …, & Liu, H. (2024). Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL. Blood. https://doi.org/10.1182/blood.2024023883

Vancouver

Zhou X, Chen X, Chen J, Wen L, Zhang Z, Qin YZ, et al. Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL. Blood. 2024. doi:10.1182/blood.2024023883

BibTeX
@article{Zhou2024,
  author = {Zhou, Xiaosu and Chen, Xue and Chen, Jiaqi and Wen, Lijun and Zhang, Zhanglin and Qin, Ya-Zhen and Cao, Panxiang and Xing, Haizhou and Mi, Yingchang and Wang, Wei and Zhang, Guangsen and Li, Ji and Wu, Huanling and Zhang, Zhifen and Zhang, Jian and Su, Zhan and Wang, Fang and Zhang, Yang and Ma, Xiaoli and Fang, Jiancheng and Wu, Ping and Wang, Tong and Fan, Gaowei and Zhao, Yang and Jin, David and Zhang, Xian and Ma, Xiujuan and Wu, Qisheng and Zhang, Zhihua and Wang, Linya and Ma, Futian and Xiao, Xia and Wu, Chengye and Sun, Kai and Tang, Ruijie and Zhang, Yun and Wu, Sanyun and Gao, Ran and Zhang, Leping and Zheng, Huyong and Zhao, Yanli and Zhu, Hong-Hu and Lu, Daopei and Lu, Peihua and Chen, Suning and Liu, Hongxing},
  title = {Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL},
  journal = {Blood},
  year = {2024},
  doi = {10.1182/blood.2024023883}
}
Kostenlos starten →